MedTrace Logo

A Scalable, Teacher-delivered, School-based Oral Health Intervention for Pakistani Lower Secondary Schoolchildren

NCT06523712 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4055

Last updated 2026-04-16

No results posted yet for this study

Summary

This was a pragmatic, two-arm, and parallel-group, superiority cluster-randomized controlled trial with 1:1 allocation of clusters (schools) to either the Smile Smarts-PK intervention arm or the control arm. The trial settings were lower secondary schools (classes 5-8) in the Punjab, Pakistan. Punjab is the most populous province of Pakistan; it has many public and low-cost private schools that serve lower- and middle-income communities.

Conditions

  • Dental Plaque
  • Cluster Randomized Trial
  • Adolescent
  • Oral Hygiene, Oral Health
  • Health Promotion
  • Pakistan

Interventions

BEHAVIORAL

Smile Smarts

The interactive oral health care lessons provided to participants in Arm 1 would involve activities and discussions aimed at changing behaviors such as tooth brushing frequency, brushing techniques, and the use of interdental aids. The intervention aims to educate and motivate participants to adopt and maintain optimal oral hygiene habits through behavioral change strategies.

Sponsors & Collaborators

  • University of Lahore

    collaborator OTHER

  • Universiti Putra Malaysia

    lead OTHER

Principal Investigators

  • MUHAMMAD ARSHED, PhD · University of Lahore

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-25
Primary Completion
2025-06-24
Completion
2025-07-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06523712 on ClinicalTrials.gov